文献速递心脏核医学

肝素不能改善低β-羟丁酸水平患者[18F]FDG PET/CT中的心肌葡萄糖代谢抑制

Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level.
PubMed 文献 · EJNMMI Res · 2024-10-08

本研究纳入155例采用高脂低碳水饮食并禁食至少12小时的患者,评估即时检测β-羟丁酸(BHB)是否有助于指导肝素预处理心脏[18F]FDG PET/CT。结果显示高BHB组84%患者达到充分葡萄糖代谢抑制(GMS),低BHB组仅57%;低BHB组中使用与未使用肝素者的GMS不足发生率无显著差异(44% vs 42%,p=0.875)。

要点

  • 高BHB水平(>0.35 mmol/L)预示更充分的GMS(84% vs 57%,p<0.001)。
  • 低BHB患者中,肝素预处理未改善GMS(不足率44% vs 42%,p=0.875)。
  • 即时检测BHB可用于预测GMS,但肝素不能弥补低BHB者的GMS不足。

核心结论

  • 高BHB水平预示充分的GMS,但普通肝素不能改善低BHB患者的GMS。

研究设计与样本

  • 单中心研究,共155例(82例男性)患者采用高脂低碳水饮食并禁食至少12小时。
  • 前63例仅测量BHB但不用于指导预处理;后续92例在BHB低(<0.35 mmol/L)时于[18F]FDG注射前15-20分钟静脉注射肝素50 IU/kg。

主要发现

  • 中位BHB水平为0.4(范围0.1-5.8)mmol/L,88例(57%)BHB>0.35 mmol/L。
  • 112例(72%)达到充分GMS;高BHB组84%(74例)达到充分GMS,低BHB组仅57%(38例),p<0.001。
  • 低BHB组中,使用肝素与未使用肝素者的GMS不足发生率无显著差异(44% vs 42%,p=0.875)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inadequate myocardial glucose metabolism suppression (GMS) can hamper interpretation of cardiac [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET/CT). Use of β-hydroxybutyrate (BHB) measurement before [18F]FDG injection has been proposed for predicting adequate GMS. However, limited information is available on BHB measurement in guiding preparations for [18F]FDG-PET/CT. The purpose of this study was to evaluate if point-of-care measured BHB is useful in guiding heparin premedication for cardiac [18F]FDG-PET/CT. RESULTS: 155 patients (82 male) had followed a high-fat, low-carbohydrate diet and fasted for at least twelve hours. For the first 63 patients, BHB was measured, but it was not used to guide premedication. For the subsequent 92 patients, heparin 50 IU/kg was injected intravenously 15-20 min before [18F]FDG injection if the BHB level was low (< 0.35 mmol/l). Cardiac [18F]FDG uptake pattern was evaluated visually and [18F]FDG uptake in the myocardium and blood pool were measured. Median BHB level was 0.4 (range 0.1-5.8) mmol/l. Eighty-eight patients (57%) reached a BHB level higher than 0.35 mmol/l. 112 patients (72%) had adequate GMS. In the high BHB group, 74 patients (84%) had adequate GMS, whereas of those with low BHB, only 38 (57%) had adequate GMS (p < 0.001). In the low BHB group, the prevalence of inadequate GMS was comparable in patients with and without heparin (44% vs. 42%, p = 0.875). CONCLUSIONS: While high BHB predicts adequate GMS, unfractionated heparin does not improve GMS in patients with low BHB.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Hartikainen S, Vepsäläinen V, Laitinen T, et al. Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level. EJNMMI Res. 2024. PMID: 39379783. doi:10.1186/s13550-024-01153-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。